234 related articles for article (PubMed ID: 18042688)
1. Non-operative breast pathology: apocrine lesions.
Wells CA; El-Ayat GA
J Clin Pathol; 2007 Dec; 60(12):1313-20. PubMed ID: 18042688
[TBL] [Abstract][Full Text] [Related]
2. Cell turnover in apocrine metaplasia and apocrine adenosis of the breast.
Elayat G; Selim AG; Wells CA
Ann Diagn Pathol; 2010 Feb; 14(1):1-7. PubMed ID: 20123450
[TBL] [Abstract][Full Text] [Related]
3. Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.
Celis JE; Moreira JM; Gromova I; Cabezón T; Gromov P; Shen T; Timmermans V; Rank F
Mol Oncol; 2007 Jun; 1(1):97-119. PubMed ID: 19383289
[TBL] [Abstract][Full Text] [Related]
4. Atypical Apocrine Adenosis: Diagnostic Challenges and Pitfalls.
Asirvatham JR; Falcone MM; Kleer CG
Arch Pathol Lab Med; 2016 Oct; 140(10):1045-51. PubMed ID: 27684975
[TBL] [Abstract][Full Text] [Related]
5. Apocrine ductal carcinoma in situ involving a sclerosing lesion with adenosis: report of a case.
Visscher DW
Arch Pathol Lab Med; 2009 Nov; 133(11):1817-21. PubMed ID: 19886717
[TBL] [Abstract][Full Text] [Related]
6. The Histologic Spectrum of Apocrine Lesions of the Breast.
Durham JR; Fechner RE
Am J Clin Pathol; 2000 May; 113(suppl_1):S3-18. PubMed ID: 11993707
[TBL] [Abstract][Full Text] [Related]
7. Surgical follow-up results for apocrine adenosis and atypical apocrine adenosis diagnosed on breast core biopsy.
Hou Y; Chaudhary S; Gao FF; Li Z
Ann Diagn Pathol; 2016 Oct; 24():4-6. PubMed ID: 27649945
[TBL] [Abstract][Full Text] [Related]
8. Atypical apocrine adenosis diagnosed on breast core biopsy: implications for management.
Calhoun BC; Booth CN
Hum Pathol; 2014 Oct; 45(10):2130-5. PubMed ID: 25106711
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
Gatalica Z
Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
[TBL] [Abstract][Full Text] [Related]
10. Fibroadenoma of the breast: analysis of associated pathological entities--a different risk marker in different age groups for concurrent breast cancer.
Shabtai M; Saavedra-Malinger P; Shabtai EL; Rosin D; Kuriansky J; Ravid-Megido M; Ben Haim M; Ayalon AH
Isr Med Assoc J; 2001 Nov; 3(11):813-7. PubMed ID: 11729575
[TBL] [Abstract][Full Text] [Related]
11. Upgrade Rate and Imaging Features of Atypical Apocrine Lesions.
Chang Sen LQ; Berg WA; Carter GJ
Breast J; 2017 Sep; 23(5):569-578. PubMed ID: 28333404
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic utility of EZH2 H-score and Ki-67 index in non-invasive breast apocrine lesions.
Vougiouklakis T; Belovarac BJ; Lytle A; Chiriboga L; Ozerdem U
Pathol Res Pract; 2020 Sep; 216(9):153041. PubMed ID: 32825929
[TBL] [Abstract][Full Text] [Related]
13. Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast.
Selim AG; El-Ayat G; Wells CA
Virchows Arch; 2002 Nov; 441(5):449-55. PubMed ID: 12447674
[TBL] [Abstract][Full Text] [Related]
14. Atypical apocrine adenosis of the breast: long-term follow-up in 37 patients.
Fuehrer N; Hartmann L; Degnim A; Allers T; Vierkant R; Frost M; Visscher D
Arch Pathol Lab Med; 2012 Feb; 136(2):179-82. PubMed ID: 22288965
[TBL] [Abstract][Full Text] [Related]
15. Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up.
Seidman JD; Ashton M; Lefkowitz M
Cancer; 1996 Jun; 77(12):2529-37. PubMed ID: 8640702
[TBL] [Abstract][Full Text] [Related]
16. [Apocrine lesions in breast pathology].
Suciu V; Menet E; Guinebretière JM; Trassard M; Vielh P
Ann Pathol; 2009 Nov; 29 Spec No 1():S112-3. PubMed ID: 19887237
[No Abstract] [Full Text] [Related]
17. Expression of androgen receptors and inhibin/activin alpha and betaA subunits in breast apocrine lesions.
Shim HS; Jung WH; Kim H; Park K; Cho NH
APMIS; 2006 May; 114(5):352-8. PubMed ID: 16725011
[TBL] [Abstract][Full Text] [Related]
18. The challenge of apocrine proliferations of the breast: a morphologic approach.
Masood S; Rosa M
Pathol Res Pract; 2009; 205(3):155-64. PubMed ID: 19147303
[TBL] [Abstract][Full Text] [Related]
19. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.
Tramm T; Kim JY; Tavassoli FA
Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240
[TBL] [Abstract][Full Text] [Related]
20. Apocrine lesions of the breast.
Quinn CM; D'Arcy C; Wells C
Virchows Arch; 2022 Jan; 480(1):177-189. PubMed ID: 34537861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]